Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merit Medical Systems (MMSI) Revenue (2016 - 2025)

Historic Revenue for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $384.2 million.

  • Merit Medical Systems' Revenue rose 1303.89% to $384.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 1140.81%. This contributed to the annual value of $1.4 billion for FY2024, which is 788.54% up from last year.
  • According to the latest figures from Q3 2025, Merit Medical Systems' Revenue is $384.2 million, which was up 1303.89% from $382.5 million recorded in Q2 2025.
  • Over the past 5 years, Merit Medical Systems' Revenue peaked at $384.2 million during Q3 2025, and registered a low of $248.9 million during Q1 2021.
  • Over the past 5 years, Merit Medical Systems' median Revenue value was $315.2 million (recorded in 2023), while the average stood at $313.8 million.
  • Data for Merit Medical Systems' Revenue shows a peak YoY increase of 2837.1% (in 2021) and a maximum YoY decrease of 221.25% (in 2021) over the last 5 years.
  • Over the past 5 years, Merit Medical Systems' Revenue (Quarter) stood at $278.5 million in 2021, then increased by 5.36% to $293.4 million in 2022, then grew by 10.6% to $324.5 million in 2023, then grew by 9.44% to $355.2 million in 2024, then rose by 8.17% to $384.2 million in 2025.
  • Its Revenue was $384.2 million in Q3 2025, compared to $382.5 million in Q2 2025 and $355.4 million in Q1 2025.